{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:27:24Z","timestamp":1764239244190},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.spen.2004.07.005","type":"journal-article","created":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T19:55:45Z","timestamp":1102362945000},"page":"214-217","source":"Crossref","is-referenced-by-count":7,"title":["Immunizations, immunology, and autism"],"prefix":"10.1016","volume":"11","author":[{"given":"Michael G.","family":"Chez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2004.07.005_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1126\/science.1086726","article-title":"Measles outbreaks in a population with declining vaccine uptake","volume":"301","author":"Jansen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.spen.2004.07.005_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2004.07.005_bib3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(05)73676-X","article-title":"Measles virus and autism","volume":"356","author":"O\u2019Leary","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2004.07.005_bib4","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1542\/peds.107.5.e84","article-title":"Measles-mumps-rubella vaccine and autistic spectrum disorder","volume":"107","author":"Halsey","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2004.07.005_bib5","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1542\/peds.108.4.e58","article-title":"No evidence for a new variant of measles-mumps-rubella-induced autism","volume":"108","author":"Fombonne","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2004.07.005_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.285.9.1183","article-title":"Time trends in autism and in MMR immunization coverage in California","volume":"285","author":"Dales","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2004.07.005_bib7","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/S0264-410X(01)00097-4","article-title":"MMR and autism","volume":"19","author":"Farrington","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.spen.2004.07.005_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","article-title":"Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners","volume":"322","author":"Kaye","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.spen.2004.07.005_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/adc.87.6.493","article-title":"Recall bias, MMR, and autism","volume":"87","author":"Andrews","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.spen.2004.07.005_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.324.7334.393","article-title":"Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism","volume":"324","author":"Taylor","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.spen.2004.07.005_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14740338.1.2.115","article-title":"MMR vaccination and autism","volume":"1","author":"DeStefano","year":"2002","journal-title":"Expert Opin Drug Safety"},{"key":"10.1016\/j.spen.2004.07.005_bib12","unstructured":"California Department of Developmental Services: Autistic Spectrum Disorders: Changes in the California Caseload. An Update, 1999 Through 2002. Sacramento, CA, California Health and Human Services Agency, April 2003"},{"key":"10.1016\/j.spen.2004.07.005_bib13","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa021134","article-title":"A population-based study of measles, mumps, and rubella vaccination and autism","volume":"347","author":"Madsen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2004.07.005_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2165\/00128072-200204100-00001","article-title":"Measles, mumps and rubella vaccine, autism and inflammatory bowel disease","volume":"4","author":"Elliman","year":"2002","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.spen.2004.07.005_bib15","first-page":"114","article-title":"An epidemiological study on Japanese autism concerning routine childhood immunization history","volume":"56","author":"Takahashi","year":"2003","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.spen.2004.07.005_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.113.2.259","article-title":"Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects","volume":"113","author":"DeStefano","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2004.07.005_bib17","first-page":"PI33","article-title":"A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism","volume":"10","author":"Geier","year":"2004","journal-title":"Med Sci Monitor"},{"key":"10.1016\/j.spen.2004.07.005_bib18","series-title":"Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. Immunization Safety Review: Vaccines and Autism","year":"2004"},{"key":"10.1016\/j.spen.2004.07.005_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.290.13.1763","article-title":"Association between thimerosal-containing vaccine and autism","volume":"290","author":"Hviid","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2004.07.005_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.112.3.604","article-title":"Thimerosal and the occurrence of autism","volume":"112","author":"Madsen","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2004.07.005_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/1363849031000139315","article-title":"An assessment of the impact of thimerosal on childhood neurodevelopmental disorders","volume":"6","author":"Geier","year":"2003","journal-title":"Pediatr Rehabil"},{"key":"10.1016\/j.spen.2004.07.005_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/153537020322800603","article-title":"Neurodevelopmental disorders after thimerosal-containing vaccines","volume":"228","author":"Geier","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.spen.2004.07.005_bib23","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0140-6736(03)13371-5","article-title":"Prenatal methymercury exposure from ocean fish consumption in the Seychelles child development study","volume":"361","author":"Myers","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2004.07.005_bib24","unstructured":"Food and Drug Administration: Thimerosal content in some currently manufactured U.S. licensed vaccines (table); available at http:\/\/www.cdc.gov\/nip\/vacsafe\/concerns\/thimersol\/default.htm (accessed September 2004)"},{"key":"10.1016\/j.spen.2004.07.005_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1365-2036.2002.01206.x","article-title":"The concept of entero-colonic encephalopathy, autism and opioid receptor ligands","volume":"16","author":"Wakefield","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.spen.2004.07.005_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.mp.4001529","article-title":"Neurotoxic effects of postnatal thimerosal are mouse strain dependent","volume":"9","author":"Hornig","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2004.07.005_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(03)14699-5","article-title":"Separating inflammation from speculation in autism","volume":"362","author":"Murch","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2004.07.005_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(04)15715-2","article-title":"Retraction of an interpretation","volume":"363","author":"Murch","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2004.07.005_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.110.5.957","article-title":"Neurologic disorders after measles-mumps-rubella vaccination","volume":"110","author":"Makela","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2004.07.005_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02256592","article-title":"Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism","volume":"9","author":"Singh","year":"2002","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.spen.2004.07.005_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2249.1991.tb05657.x","article-title":"Increased frequency of the null allele at the complement C4B locus in autism","volume":"83","author":"Warren","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.spen.2004.07.005_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/088307389901400608","article-title":"Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism","volume":"14","author":"Comi","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2004.07.005_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01531729","article-title":"Immune abnormalities in patients with autism","volume":"16","author":"Warren","year":"1986","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.spen.2004.07.005_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01531114","article-title":"Depressed lymphocyte responsiveness in autistic children","volume":"7","author":"Stubbs","year":"1977","journal-title":"J Autism Child Schizophr"},{"key":"10.1016\/j.spen.2004.07.005_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/clin.1998.4588","article-title":"Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism","volume":"89","author":"Singh","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.spen.2004.07.005_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/brbi.1993.1010","article-title":"Antibodies to myelin basic protein in children with autistic behavior","volume":"7","author":"Singh","year":"1993","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.spen.2004.07.005_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02172828","article-title":"Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics","volume":"26","author":"Gupta","year":"1996","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.spen.2004.07.005_bib38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0006-3223(88)90012-1","article-title":"Antibrain antibodies in infantile autism","volume":"23","author":"Todd","year":"1988","journal-title":"Biol Psychol"},{"key":"10.1016\/j.spen.2004.07.005_bib39","first-page":"12","article-title":"Immunoglobulin reactivity in autism and Rett\u2019s syndrome","volume":"7","author":"Plioplys","year":"1994","journal-title":"Dev Brain Dys"},{"key":"10.1016\/j.spen.2004.07.005_bib40","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(97)70272-5","article-title":"Serum autoantibodies in childhood opsoclonus-myoclonus syndrome","volume":"130","author":"Connolly","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2004.07.005_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(95)00161-1","article-title":"Immunoreactive S100 proteins of blood immunocytes and brain cells","volume":"64","author":"Singh","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2004.07.005_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004583-198705000-00008","article-title":"Reduced natural killer cell activity in autism","volume":"26","author":"Warren","year":"1987","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2004.07.005_bib43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00004583-199508000-00010","article-title":"Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder?","volume":"34","author":"Warren","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2004.07.005_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000119172","article-title":"DR-positive T cells in autism","volume":"31","author":"Warren","year":"1995","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.spen.2004.07.005_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08820139009041839","article-title":"Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism","volume":"19","author":"Warren","year":"1990","journal-title":"Immunol Invest"},{"key":"10.1016\/j.spen.2004.07.005_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3476(99)70248-9","article-title":"Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders","volume":"134","author":"Connelly","year":"1999","journal-title":"J Pediatr"},{"issue":"Suppl","key":"10.1016\/j.spen.2004.07.005_bib47","first-page":"183","article-title":"The presence of autoantibodies in idiopathic\/acquired versus genetic variants of pediatric epilepsy","volume":"41","author":"Chez","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2004.07.005_bib48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.1024","article-title":"Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation","volume":"49","author":"Nelson","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2004.07.005_bib49","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1001\/jama.284.24.3104","article-title":"Pediatric obsessive-compulsive disorder","volume":"284","author":"Snider","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2004.07.005_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3999(02)00582-2","article-title":"PANDAS","volume":"55","author":"Singer","year":"2003","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.spen.2004.07.005_bib51","first-page":"217","article-title":"Treatment of electroencephalographic epileptiform activity on overnight EEG Studies in children with pervasive developmental disorder or autism","volume":"2","author":"Chez","year":"1998","journal-title":"J Dev Learn Disord"},{"key":"10.1016\/j.spen.2004.07.005_bib52","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00004583-199508000-00022","article-title":"Case study","volume":"34","author":"Stefanatos","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2004.07.005_bib53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1005568027292","article-title":"Immunological treatments for autism","volume":"30","author":"Gupta","year":"2000","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.spen.2004.07.005_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/088307389801300207","article-title":"Intravenous immunoglobulin treatment of children with autism","volume":"13","author":"Plioplys","year":"1999","journal-title":"J Child Neurol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909104000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909104000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T14:00:26Z","timestamp":1549029626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909104000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1071909104000610"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2004.07.005","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}